Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Roswell Shelhamer, Michael Rodriguez

Premium

Cambridge Isotope Laboratories said this week that it has hired Roswell Shelhamer as business development manager.

Shelhamer previously held a sales position at Isotec, a division of Sigma-Aldrich.


Epic Sciences has tapped Michael Rodriguez to be company CFO.

Rodriguez previously was COO at Clarient Diagnostic Services, where he led a group of more than 350 people in lab operations, IT, quality assurance, and other areas. He also formerly was senior VP and CFO at Endocare, executive VP and CFO of Directfit, and an executive at Tickets.com and EDiX Corporation.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.